"ProtocolName","LabelName","GroupValues","Size","Estimator","RMSE","Correlation"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Weka RF folded fingerprints regression","0.8466318847058238","0.7907532536349359"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","RBF libSVM folded fingerprints regression","0.9142521749205337","0.7634752022821398"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Tanimoto Smile SVM regression","0.9093042419525779","0.7633691975621528"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Poly Smile SVM fingerprints regression","0.9180462400861173","0.7590010028586367"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Weka RF descriptors regression","0.923595572469408","0.7454366208513132"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Elastic Net on folded fingerprints regression","1.0080974034592813","0.7109826162588514"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","RBF Smile SVM descriptors regression","1.0240384566209397","0.7039620571248631"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","RBF libSVM folded fingerprints regression","0.8408489464708342","0.8134706654229681"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Poly Smile SVM fingerprints regression","0.8482594094215267","0.8093349057825523"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Tanimoto Smile SVM regression","0.8537250565930763","0.8070180568106871"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","RBF Smile SVM descriptors regression","0.8656356976229572","0.803459060212225"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Weka RF folded fingerprints regression","0.8739920168546894","0.8000089909852318"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Elastic Net on folded fingerprints regression","0.8764837463063349","0.7955307423250405"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Weka RF descriptors regression","0.9065993346151473","0.7807554342214514"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Tanimoto Smile SVM regression","0.5143840753981471","0.7455042985725117"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","RBF libSVM folded fingerprints regression","0.5226533526978288","0.7336930381362635"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Elastic Net on folded fingerprints regression","0.5302555305914847","0.7284893287679309"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Weka RF folded fingerprints regression","0.5414898294586482","0.7162232729805829"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Poly Smile SVM fingerprints regression","0.5575825661943163","0.6891060222179175"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Weka RF descriptors regression","0.6187495940489559","0.5887932978525573"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","RBF Smile SVM descriptors regression","0.6951310281079419","0.4856973689969049"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","RBF libSVM folded fingerprints regression","0.623245337456782","0.8085937607688769"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Tanimoto Smile SVM regression","0.6603636318494395","0.7870726657698321"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Elastic Net on folded fingerprints regression","0.655852151034197","0.7812795576061571"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Poly Smile SVM fingerprints regression","0.6596400608754446","0.7745492615792335"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Weka RF folded fingerprints regression","0.750315536423547","0.6932583919186879"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","RBF Smile SVM descriptors regression","0.9120736139024579","0.5177013824551097"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Weka RF descriptors regression","0.9925958843398953","0.3684247590766251"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Elastic Net on folded fingerprints regression","0.4704183779126591","0.798923794970115"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Poly Smile SVM fingerprints regression","0.4731182803198258","0.7952826584417382"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","RBF libSVM folded fingerprints regression","0.4800821472357888","0.7899563734171732"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Tanimoto Smile SVM regression","0.48795278630428646","0.7765538285835472"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Weka RF folded fingerprints regression","0.4942145318770177","0.7690653306751332"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","RBF Smile SVM descriptors regression","0.6436094597808981","0.5971334579060322"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Weka RF descriptors regression","0.641793437573249","0.5587986007685036"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Poly Smile SVM fingerprints regression","0.8433652364798689","0.7544129285851662"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","RBF libSVM folded fingerprints regression","0.850875216511043","0.750198097810771"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Weka RF folded fingerprints regression","0.8958463276798847","0.7190254157560168"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Tanimoto Smile SVM regression","0.902113803044277","0.7162741788890847"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Elastic Net on folded fingerprints regression","0.9264138764357489","0.7031685909098833"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Weka RF descriptors regression","0.9309243992445554","0.6921010126043734"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","RBF Smile SVM descriptors regression","0.9712620590049784","0.670343128172176"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","RBF libSVM folded fingerprints regression","0.8703360033219253","0.7764712156874134"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Poly Smile SVM fingerprints regression","0.8706194545602977","0.7753936173473449"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Weka RF folded fingerprints regression","0.8764017858493035","0.7718469208027132"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Tanimoto Smile SVM regression","0.8778265356634237","0.7701145976451077"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Elastic Net on folded fingerprints regression","0.8862931339073393","0.7668910413521264"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","RBF Smile SVM descriptors regression","0.9717103427833688","0.7164040338276442"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Weka RF descriptors regression","0.9722954075055997","0.709465809827176"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Elastic Net on folded fingerprints regression","0.4953003522134871","0.8357376941560328"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","RBF libSVM folded fingerprints regression","0.49814238257613586","0.8333934847265404"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Poly Smile SVM fingerprints regression","0.5017740961570216","0.8306287269317058"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Tanimoto Smile SVM regression","0.5451658826411601","0.7972044386167096"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Weka RF folded fingerprints regression","0.5694917982877471","0.7852431897343274"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","RBF Smile SVM descriptors regression","0.7335102439647252","0.6394633896828766"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Weka RF descriptors regression","0.7683283526173647","0.5345818244371741"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","RBF libSVM folded fingerprints regression","0.3303904752477883","0.7794018932388852"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Elastic Net on folded fingerprints regression","0.32887387115567607","0.7789251940572797"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Weka RF folded fingerprints regression","0.34250521802111167","0.7660461646919732"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Tanimoto Smile SVM regression","0.3429286848831258","0.7557246808854887"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Poly Smile SVM fingerprints regression","0.34965768923070345","0.7507127525430624"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","RBF Smile SVM descriptors regression","0.43534592670762","0.5851917824197291"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Weka RF descriptors regression","0.47137291288919575","0.4385421457512166"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","RBF libSVM folded fingerprints regression","0.31662756925984087","0.7949032895850376"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Elastic Net on folded fingerprints regression","0.3270253628117866","0.7757158946298218"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Tanimoto Smile SVM regression","0.3271190831930112","0.7751150058407336"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Weka RF folded fingerprints regression","0.33568740795678964","0.7704218754678424"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Poly Smile SVM fingerprints regression","0.34355116477467135","0.7615174281542217"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","RBF Smile SVM descriptors regression","0.4168563019010363","0.606299544670707"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Weka RF descriptors regression","0.46222195331955607","0.4504131885092814"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Elastic Net on folded fingerprints regression","0.3985295944352077","0.7695588785594396"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","RBF libSVM folded fingerprints regression","0.4031383883152954","0.7691371390632639"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Weka RF folded fingerprints regression","0.42754815682049685","0.7455314673014815"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Poly Smile SVM fingerprints regression","0.43092382418604547","0.733737024582753"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Tanimoto Smile SVM regression","0.43405926820681284","0.7219236017780699"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","RBF Smile SVM descriptors regression","0.5360540837112534","0.5492287150554808"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Weka RF descriptors regression","0.565359284658437","0.424167054253448"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","RBF libSVM folded fingerprints regression","0.7164858685133337","0.6742973112001504"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Poly Smile SVM fingerprints regression","0.718725350027552","0.6721599464830834"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Elastic Net on folded fingerprints regression","0.7202583792302582","0.6681653039178604"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Tanimoto Smile SVM regression","0.7429709414177413","0.639983040979529"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Weka RF folded fingerprints regression","0.7615317871038748","0.6231750208669441"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","RBF Smile SVM descriptors regression","0.784587330110926","0.5887411020932366"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Weka RF descriptors regression","0.8144160534718402","0.5442323870662041"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","RBF libSVM folded fingerprints regression","0.7342999555656424","0.7716923984193275"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Tanimoto Smile SVM regression","0.7508927273100833","0.7589088581194775"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Elastic Net on folded fingerprints regression","0.7565095378745826","0.7564924224969828"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Weka RF folded fingerprints regression","0.7807857246370065","0.7446734017808642"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Poly Smile SVM fingerprints regression","0.7724370802322467","0.7430809539438583"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Weka RF descriptors regression","0.8223776594158178","0.7044485265152468"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","RBF Smile SVM descriptors regression","0.8608287171281068","0.67827078436744"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","RBF libSVM folded fingerprints regression","0.772386732159674","0.8744217093737442"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Poly Smile SVM fingerprints regression","0.7913646553308943","0.8687995444592435"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Elastic Net on folded fingerprints regression","0.821684311233697","0.8557396417504264"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Tanimoto Smile SVM regression","0.8256840598374681","0.8545798912451859"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Weka RF folded fingerprints regression","0.8612644764241127","0.8417328477594365"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","RBF Smile SVM descriptors regression","0.859216376908148","0.841688325381886"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Weka RF descriptors regression","0.9432489780025972","0.8081292049273732"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","RBF libSVM folded fingerprints regression","0.815331321282856","0.7053645786091641"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Poly Smile SVM fingerprints regression","0.8413029688663299","0.6863063333796798"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Tanimoto Smile SVM regression","0.8413494676440544","0.6800691790839675"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Elastic Net on folded fingerprints regression","0.8663943307034313","0.6647005159480331"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Weka RF folded fingerprints regression","0.8715364498452965","0.6504048795325653"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Weka RF descriptors regression","0.9249228374051701","0.5899245763555654"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","RBF Smile SVM descriptors regression","0.9488240820741226","0.5882775901651801"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","RBF libSVM folded fingerprints regression","0.7604496007102944","0.8267549667302775"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Poly Smile SVM fingerprints regression","0.7645900307050949","0.824657303716291"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Tanimoto Smile SVM regression","0.7906936382736715","0.8111459888609449"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Weka RF folded fingerprints regression","0.816537064173219","0.8034413502812938"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Elastic Net on folded fingerprints regression","0.817098102593931","0.7979090029387998"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","RBF Smile SVM descriptors regression","0.9056101062786635","0.745005335753595"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Weka RF descriptors regression","0.9240947053202904","0.7390419844932952"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Poly Smile SVM fingerprints regression","0.821839765661674","0.8140239774417255"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Tanimoto Smile SVM regression","0.8228600351180664","0.8130705255992101"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Weka RF folded fingerprints regression","0.8303566767080054","0.809231272154127"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","RBF libSVM folded fingerprints regression","0.8362885341748564","0.8080085314767491"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","RBF Smile SVM descriptors regression","0.8655632237526953","0.7943003999199926"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Weka RF descriptors regression","0.8709219841658776","0.7874316282428571"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Elastic Net on folded fingerprints regression","0.8949192972550307","0.7782308121018444"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Tanimoto Smile SVM regression","0.7442855710241684","0.8233570457629665"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Poly Smile SVM fingerprints regression","0.7683595558172372","0.809702913160356"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","RBF libSVM folded fingerprints regression","0.7735867041278974","0.8068082750466081"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Weka RF folded fingerprints regression","0.8005024323747443","0.7978499757822342"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","RBF Smile SVM descriptors regression","0.8065803564493549","0.7891128126435673"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Weka RF descriptors regression","0.872265984080759","0.7573904527216672"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Elastic Net on folded fingerprints regression","0.8774958195925263","0.7462375176233279"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Tanimoto Smile SVM regression","0.7511411610094251","0.813138375341544"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","RBF libSVM folded fingerprints regression","0.7622860629729459","0.8059294555207839"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Poly Smile SVM fingerprints regression","0.7637361622221658","0.8058509395056017"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Weka RF folded fingerprints regression","0.8104324248851131","0.7846485152549668"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","RBF Smile SVM descriptors regression","0.8037118034950345","0.7822172972037199"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Elastic Net on folded fingerprints regression","0.8528614312202595","0.7517508233638169"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Weka RF descriptors regression","0.9058607100806666","0.7207696318261944"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","RBF Smile SVM descriptors regression","0.6205256768010513","0.8855189105616873"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Weka RF descriptors regression","0.648287974548431","0.8742220652592742"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Tanimoto Smile SVM regression","0.6630200184058627","0.8678673039136786"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Poly Smile SVM fingerprints regression","0.6762126226493083","0.8627418345424953"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","RBF libSVM folded fingerprints regression","0.6790744949923642","0.8623907001220502"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Weka RF folded fingerprints regression","0.6933150763552265","0.8545720419780047"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Elastic Net on folded fingerprints regression","0.7989419787048586","0.803040342141423"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","RBF Smile SVM descriptors regression","0.6205256768010513","0.8855189105616873"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Weka RF descriptors regression","0.648287974548431","0.8742220652592742"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Tanimoto Smile SVM regression","0.6630200184058627","0.8678673039136786"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Poly Smile SVM fingerprints regression","0.6762126226493083","0.8627418345424953"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","RBF libSVM folded fingerprints regression","0.6790744949923642","0.8623907001220502"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Weka RF folded fingerprints regression","0.6933150763552265","0.8545720419780047"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Elastic Net on folded fingerprints regression","0.7989419787048586","0.803040342141423"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Tanimoto Smile SVM regression","0.9969132446171505","0.7019047189712249"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","RBF libSVM folded fingerprints regression","1.0289634305097999","0.6770191671877436"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Elastic Net on folded fingerprints regression","1.0604916231048644","0.66453215574309"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Poly Smile SVM fingerprints regression","1.0733824947657578","0.647500340146747"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","RBF Smile SVM descriptors regression","1.0706772187067184","0.6469140326496555"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Weka RF folded fingerprints regression","1.1012179644742117","0.6203780461252242"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Weka RF descriptors regression","1.13566021889332","0.5831572347119517"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","RBF libSVM folded fingerprints regression","0.7554594139955452","0.8134164130415358"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","RBF Smile SVM descriptors regression","0.7648347340009671","0.8099753179994617"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Poly Smile SVM fingerprints regression","0.7691006995539096","0.8078633409230412"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Weka RF descriptors regression","0.7933112432845683","0.8029209381483795"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Tanimoto Smile SVM regression","0.7878449080975225","0.7955103000822046"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Weka RF folded fingerprints regression","0.8824052001717957","0.7598977736656336"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Elastic Net on folded fingerprints regression","0.8609178787347692","0.7525206950586595"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","RBF libSVM folded fingerprints regression","0.7659116389912884","0.8428399840790072"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Poly Smile SVM fingerprints regression","0.7842965012848528","0.8352854109830165"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Elastic Net on folded fingerprints regression","0.8208238580143741","0.8143004872161206"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Weka RF folded fingerprints regression","0.8480759051240581","0.8066708517104352"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Tanimoto Smile SVM regression","0.8740151264741872","0.7896959636447689"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Weka RF descriptors regression","0.8868802162917275","0.7862473431627813"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","RBF Smile SVM descriptors regression","0.9156291719819408","0.7670223372572192"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","RBF Smile SVM descriptors regression","0.22912499594876837","0.863519716629831"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Weka RF folded fingerprints regression","0.23582073459610722","0.860839601959499"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Tanimoto Smile SVM regression","0.2581309859017196","0.8221256255304052"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","RBF libSVM folded fingerprints regression","0.2610811054359275","0.8185233544217296"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Elastic Net on folded fingerprints regression","0.2684639652692518","0.8057791199779558"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Weka RF descriptors regression","0.2839430657849435","0.7792572647238619"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Poly Smile SVM fingerprints regression","0.3406269927434898","0.7439830694402257"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Weka RF folded fingerprints regression","0.48232430895260925","0.5964147596554006"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Tanimoto Smile SVM regression","0.49433155862446715","0.5700171134229721"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Poly Smile SVM fingerprints regression","0.5136978451226102","0.5186335718720894"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","RBF libSVM folded fingerprints regression","0.5159739107301783","0.5157193875094269"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Elastic Net on folded fingerprints regression","0.5286125639379861","0.5124939475805762"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Weka RF descriptors regression","0.5217490032649892","0.4968819041638374"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","RBF Smile SVM descriptors regression","0.5779628105111131","0.39181344138957463"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","RBF libSVM folded fingerprints regression","0.590049788162903","0.8042658384189599"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Poly Smile SVM fingerprints regression","0.6087408161574474","0.7902886032443176"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Elastic Net on folded fingerprints regression","0.6463235058913401","0.7691224765335528"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Tanimoto Smile SVM regression","0.6471618414487555","0.7605120946878025"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Weka RF folded fingerprints regression","0.6562074953572463","0.7594602572683495"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","RBF Smile SVM descriptors regression","0.724155900249177","0.6942039417193245"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Weka RF descriptors regression","0.7373321687441731","0.6778038398765942"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Elastic Net on folded fingerprints regression","0.7331809902096548","0.7183644261556871"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Poly Smile SVM fingerprints regression","0.7436451505818212","0.7068901558275587"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Weka RF folded fingerprints regression","0.7503763238519069","0.7044867966644826"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","RBF libSVM folded fingerprints regression","0.7457586398671261","0.7040946729970359"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","RBF Smile SVM descriptors regression","0.7947033129472116","0.6678249338477795"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Tanimoto Smile SVM regression","0.7990073622071845","0.6570084738862312"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Weka RF descriptors regression","0.8019395333256948","0.6472086388643243"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Tanimoto Smile SVM regression","0.7361604186622885","0.7973374443755511"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","RBF libSVM folded fingerprints regression","0.7534152493123336","0.7877899231490879"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Weka RF folded fingerprints regression","0.782582409951331","0.7787409498208033"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Poly Smile SVM fingerprints regression","0.7704171547051459","0.7759487424126643"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","RBF Smile SVM descriptors regression","0.7721848077239242","0.7702510919506139"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Elastic Net on folded fingerprints regression","0.8503188106348429","0.7204090442939615"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Weka RF descriptors regression","0.8621842958078616","0.7080237392392199"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Elastic Net on folded fingerprints regression","0.5384529118244817","0.9011627169969119"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","RBF libSVM folded fingerprints regression","0.586601775626917","0.8883383483424139"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Poly Smile SVM fingerprints regression","0.6029379205322043","0.8797779105739476"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Tanimoto Smile SVM regression","0.6230878353481836","0.8700307498548028"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Weka RF folded fingerprints regression","0.6756439114212002","0.8453894466855107"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","RBF Smile SVM descriptors regression","0.7827127909001105","0.776651273680053"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Weka RF descriptors regression","0.886269958477548","0.7008271987625725"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","RBF libSVM folded fingerprints regression","0.695483000224902","0.7526098857097929"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Elastic Net on folded fingerprints regression","0.7193265211158937","0.7340148602399705"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Poly Smile SVM fingerprints regression","0.7205263788744033","0.7339702143958978"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Tanimoto Smile SVM regression","0.7350448346657029","0.7165651926710978"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Weka RF folded fingerprints regression","0.7605204242628486","0.7057040407597599"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Weka RF descriptors regression","0.7996940843955419","0.6570441360870115"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","RBF Smile SVM descriptors regression","0.8492502032373394","0.6197932375798554"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Poly Smile SVM fingerprints regression","0.6656678304946825","0.8349724131875988"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","RBF libSVM folded fingerprints regression","0.6648517372186934","0.8346721861284676"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Weka RF folded fingerprints regression","0.6854034451006533","0.8267319297954632"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Tanimoto Smile SVM regression","0.7080740050419931","0.8134793659671349"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Elastic Net on folded fingerprints regression","0.73569919432648","0.7994021680758653"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","RBF Smile SVM descriptors regression","0.7743189449771206","0.7710694198411926"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Weka RF descriptors regression","0.8351663384123373","0.7203597552754616"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Weka RF folded fingerprints regression","0.7860968827734435","0.5461469033854969"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Tanimoto Smile SVM regression","0.8090000879859981","0.5219019405958085"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","RBF libSVM folded fingerprints regression","0.8156585312498755","0.515707684786032"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Poly Smile SVM fingerprints regression","0.8273210707064217","0.5061908873885815"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","RBF Smile SVM descriptors regression","0.8798637214334821","0.44915254296023915"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Weka RF descriptors regression","0.8456185626825481","0.43511621096300485"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Elastic Net on folded fingerprints regression","0.895146875349168","0.4296726606250866"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Tanimoto Smile SVM regression","0.748610751490303","0.862782842360563"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","RBF libSVM folded fingerprints regression","0.7612657027492572","0.8582805658520472"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Weka RF folded fingerprints regression","0.7832506350094025","0.8557495333080993"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Poly Smile SVM fingerprints regression","0.7713965156882295","0.8536648167959432"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Elastic Net on folded fingerprints regression","0.8093988956271527","0.8382538691440136"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","RBF Smile SVM descriptors regression","0.8507656505302573","0.8186273235173709"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Weka RF descriptors regression","0.910091028688741","0.800572100743329"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Tanimoto Smile SVM regression","0.5978928483867019","0.7144683417466373"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","RBF libSVM folded fingerprints regression","0.6026112998650637","0.6999950468073924"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Poly Smile SVM fingerprints regression","0.6323833082439493","0.6581938422411588"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Weka RF folded fingerprints regression","0.6622997577889043","0.6313884659360682"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Elastic Net on folded fingerprints regression","0.669824972679446","0.6108151083932482"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","RBF Smile SVM descriptors regression","0.7233890430060516","0.5078802532495527"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Weka RF descriptors regression","0.720846241373781","0.5000246802719864"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Poly Smile SVM fingerprints regression","0.5804902297511144","0.885148260503971"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","RBF libSVM folded fingerprints regression","0.5888613465241936","0.8803010318671912"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Elastic Net on folded fingerprints regression","0.6147888339081968","0.865621787683769"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Tanimoto Smile SVM regression","0.6474983592090918","0.84928812003399"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Weka RF folded fingerprints regression","0.6635390386529917","0.840968062199222"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","RBF Smile SVM descriptors regression","0.6898603676587187","0.8275208985211661"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Weka RF descriptors regression","0.7009176065347917","0.8243973632163001"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","RBF libSVM folded fingerprints regression","0.6380246761693789","0.8760516702444247"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Weka RF folded fingerprints regression","0.6485401889130744","0.861714700154716"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Poly Smile SVM fingerprints regression","0.672872846442587","0.8614275549989963"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Elastic Net on folded fingerprints regression","0.6816511613948266","0.84881174437252"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Tanimoto Smile SVM regression","0.6815122529559428","0.8438651857149891"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Weka RF descriptors regression","0.7110058860583035","0.8299688934083953"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","RBF Smile SVM descriptors regression","0.8043263547648484","0.7783254295957088"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","RBF Smile SVM descriptors regression","0.8241172821769354","0.5700904937943908"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Tanimoto Smile SVM regression","0.8207214885563044","0.548700733643062"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","RBF libSVM folded fingerprints regression","0.8414401223670158","0.5260900694010167"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Weka RF descriptors regression","0.8441910557903045","0.506433740942002"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Poly Smile SVM fingerprints regression","0.8762007554832915","0.4843410556331843"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Weka RF folded fingerprints regression","0.8819150606432863","0.4436296200496739"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Elastic Net on folded fingerprints regression","0.9357113591258216","0.42162357641847437"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Tanimoto Smile SVM regression","0.7498867028158334","0.745577082723563"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Elastic Net on folded fingerprints regression","0.8067894655783281","0.7040895350243299"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","RBF libSVM folded fingerprints regression","0.8103022824972087","0.6959385282099283"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Weka RF folded fingerprints regression","0.825091582849317","0.6894818952515345"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Poly Smile SVM fingerprints regression","0.8241450235080854","0.6855685983659435"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","RBF Smile SVM descriptors regression","0.897424047189478","0.6319477586546242"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Weka RF descriptors regression","0.8755917292142952","0.6285093400755697"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Elastic Net on folded fingerprints regression","0.3523856327596124","0.3397513991724324"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF folded fingerprints regression","0.350520108657194","0.3200020395970568"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Poly Smile SVM fingerprints regression","0.35825289361814516","0.30825837638071013"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF descriptors regression","0.35215727277577064","0.3079040620456525"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","RBF libSVM folded fingerprints regression","0.3683628412742606","0.28564548384312366"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","RBF Smile SVM descriptors regression","0.37673279969899576","0.26362709282236213"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Tanimoto Smile SVM regression","0.36887659739949624","0.25746645317697403"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Elastic Net on folded fingerprints regression","0.3523856327596124","0.3397513991724324"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF folded fingerprints regression","0.350520108657194","0.3200020395970568"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Poly Smile SVM fingerprints regression","0.35825289361814516","0.30825837638071013"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF descriptors regression","0.35215727277577064","0.3079040620456525"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","RBF libSVM folded fingerprints regression","0.3683628412742606","0.28564548384312366"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","RBF Smile SVM descriptors regression","0.37673279969899576","0.26362709282236213"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Tanimoto Smile SVM regression","0.36887659739949624","0.25746645317697403"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Elastic Net on folded fingerprints regression","0.3523856327596124","0.3397513991724324"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Weka RF folded fingerprints regression","0.350520108657194","0.3200020395970568"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Poly Smile SVM fingerprints regression","0.35825289361814516","0.30825837638071013"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Weka RF descriptors regression","0.35215727277577064","0.3079040620456525"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","RBF libSVM folded fingerprints regression","0.3683628412742606","0.28564548384312366"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","RBF Smile SVM descriptors regression","0.37673279969899576","0.26362709282236213"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Tanimoto Smile SVM regression","0.36887659739949624","0.25746645317697403"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Tanimoto Smile SVM regression","0.5948853485151145","0.3897074905757846"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","RBF libSVM folded fingerprints regression","0.6063957201658656","0.35602054809396444"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Poly Smile SVM fingerprints regression","0.6076832700788511","0.32444136447835126"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Elastic Net on folded fingerprints regression","0.6308196002562264","0.30420615920300625"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF descriptors regression","0.6041730093173291","0.2964684555850754"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF folded fingerprints regression","0.6013010600036116","0.295631070882216"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","RBF Smile SVM descriptors regression","0.6583033059513413","0.268943689115418"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Tanimoto Smile SVM regression","0.5948853485151145","0.3897074905757846"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","RBF libSVM folded fingerprints regression","0.6063957201658656","0.35602054809396444"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Poly Smile SVM fingerprints regression","0.6076832700788511","0.32444136447835126"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Elastic Net on folded fingerprints regression","0.6308196002562264","0.30420615920300625"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF descriptors regression","0.6041730093173291","0.2964684555850754"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF folded fingerprints regression","0.6013010600036116","0.295631070882216"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","RBF Smile SVM descriptors regression","0.6583033059513413","0.268943689115418"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Tanimoto Smile SVM regression","0.5948853485151135","0.38970749057578685"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","RBF libSVM folded fingerprints regression","0.6063957201658656","0.35602054809396444"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Poly Smile SVM fingerprints regression","0.6076832700788511","0.32444136447835126"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Elastic Net on folded fingerprints regression","0.6308196002559832","0.3042061592035557"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Weka RF descriptors regression","0.6042571211781624","0.29618942409298027"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Weka RF folded fingerprints regression","0.6013010600036116","0.295631070882216"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","RBF Smile SVM descriptors regression","0.6583032903950312","0.26894371839036557"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF descriptors regression","0.588481789399207","0.34712234663870933"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","RBF libSVM folded fingerprints regression","0.6343717294099106","0.28534756609241985"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Poly Smile SVM fingerprints regression","0.6237614643127474","0.2676730484152761"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Tanimoto Smile SVM regression","0.6501802873808327","0.2602266284299274"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","RBF Smile SVM descriptors regression","0.6777947297015595","0.2579992729897017"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF folded fingerprints regression","0.6151997408035996","0.25628182551775613"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Elastic Net on folded fingerprints regression","0.6516218637301135","0.21967483774870264"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF descriptors regression","0.588481789399207","0.34712234663870933"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","RBF libSVM folded fingerprints regression","0.6343717294099106","0.28534756609241985"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Poly Smile SVM fingerprints regression","0.6237614643127474","0.2676730484152761"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Tanimoto Smile SVM regression","0.6501802873808327","0.2602266284299274"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","RBF Smile SVM descriptors regression","0.6777947297015595","0.2579992729897017"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF folded fingerprints regression","0.6151997408035996","0.25628182551775613"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Elastic Net on folded fingerprints regression","0.6516218637301135","0.21967483774870264"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Weka RF descriptors regression","0.588481789399207","0.34712234663870933"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","RBF libSVM folded fingerprints regression","0.6343717294099106","0.28534756609241985"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Poly Smile SVM fingerprints regression","0.6237614643127474","0.2676730484152761"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Tanimoto Smile SVM regression","0.6501802873808327","0.2602266284299274"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","RBF Smile SVM descriptors regression","0.6777947297015595","0.2579992729897017"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Weka RF folded fingerprints regression","0.6151997408035996","0.25628182551775613"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Elastic Net on folded fingerprints regression","0.6516218637301135","0.21967483774870264"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Weka RF descriptors regression","0.8095486804853573","0.8132580483418116"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Poly Smile SVM fingerprints regression","0.8170424010385854","0.806133833581638"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Tanimoto Smile SVM regression","0.8200177490639143","0.8045379384931314"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","RBF Smile SVM descriptors regression","0.8259223239005384","0.8014691651305402"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Weka RF folded fingerprints regression","0.829178847387115","0.8013139209009542"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","RBF libSVM folded fingerprints regression","0.8416915031195942","0.7942946063609624"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Elastic Net on folded fingerprints regression","0.941950509489414","0.7481976667957806"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Tanimoto Smile SVM regression","0.7598961048801106","0.5644731655987789"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","RBF Smile SVM descriptors regression","0.9158142508691797","0.424150326092103"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Elastic Net on folded fingerprints regression","0.8785874433579257","0.40983369085884364"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Weka RF descriptors regression","0.864734223667981","0.4059548004937525"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Weka RF folded fingerprints regression","0.8487184277857561","0.40551781570651396"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","RBF libSVM folded fingerprints regression","0.8883627109850966","0.3839930228515158"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Poly Smile SVM fingerprints regression","0.9644335447284361","0.3016216855691863"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Poly Smile SVM fingerprints regression","0.6813241539445284","0.8151143190035518"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","RBF libSVM folded fingerprints regression","0.697083497219642","0.8058567613161635"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Weka RF folded fingerprints regression","0.7404793555516247","0.7905568237350528"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Tanimoto Smile SVM regression","0.7218216511676999","0.790128011256547"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Elastic Net on folded fingerprints regression","0.7615846188708684","0.7665761556088928"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","RBF Smile SVM descriptors regression","0.8052631486863725","0.7351885426291682"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Weka RF descriptors regression","0.8473978307636252","0.697689583873655"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Tanimoto Smile SVM regression","0.7056800637253291","0.8582986585321861"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","RBF Smile SVM descriptors regression","0.7119720978723624","0.8550137007514739"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","RBF libSVM folded fingerprints regression","0.7148368859783214","0.853832322811952"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Elastic Net on folded fingerprints regression","0.7268683287809825","0.8488640824869887"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Poly Smile SVM fingerprints regression","0.7307318487519645","0.8465449907062834"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Weka RF folded fingerprints regression","0.7516848503216794","0.8385530218622496"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Weka RF descriptors regression","0.7945781378924358","0.8190901754564962"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Tanimoto Smile SVM regression","0.9119335280068592","0.8045862026721619"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","RBF libSVM folded fingerprints regression","0.9339545304471654","0.7922053875221431"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Weka RF folded fingerprints regression","0.957948049610604","0.782118847508819"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Poly Smile SVM fingerprints regression","0.9732857738827502","0.7717324058930208"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Elastic Net on folded fingerprints regression","1.0082981976328587","0.7563829807313618"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","RBF Smile SVM descriptors regression","1.0471214160313513","0.7322394550810385"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Weka RF descriptors regression","1.0632538491550025","0.7246872651787105"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Tanimoto Smile SVM regression","0.7649505527900045","0.4359139461156382"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Poly Smile SVM fingerprints regression","0.8004301756727966","0.427422165123916"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Elastic Net on folded fingerprints regression","0.7962548510916864","0.42050189970027707"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","RBF libSVM folded fingerprints regression","0.8061197072484035","0.4063207530068334"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Weka RF folded fingerprints regression","0.7965737783438797","0.3497264966068159"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","RBF Smile SVM descriptors regression","0.8148975844138735","0.34657603707846946"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Weka RF descriptors regression","0.8522261525670033","0.2292388155821403"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","RBF libSVM folded fingerprints regression","0.6571628186293788","0.7946431775679856"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Poly Smile SVM fingerprints regression","0.6750398170428293","0.7823234984286614"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Elastic Net on folded fingerprints regression","0.6829986213835926","0.7802794634938218"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Tanimoto Smile SVM regression","0.7260689375097024","0.7431523733484527"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Weka RF descriptors regression","0.7484396763613581","0.7247821212941488"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Weka RF folded fingerprints regression","0.7561921877418497","0.7216940429743051"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","RBF Smile SVM descriptors regression","0.77724297726196","0.7041809781225644"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","RBF libSVM folded fingerprints regression","0.4611162981069362","0.907399733718575"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Poly Smile SVM fingerprints regression","0.46672099969794806","0.9068838986346209"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Tanimoto Smile SVM regression","0.4765498626726363","0.9030692049437516"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Elastic Net on folded fingerprints regression","0.4989372556013071","0.8944015820629014"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Weka RF folded fingerprints regression","0.502846268147293","0.8915874387275684"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","RBF Smile SVM descriptors regression","0.5250899123772346","0.8793979099852223"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Weka RF descriptors regression","0.5930176568590314","0.8429227581264407"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Poly Smile SVM fingerprints regression","0.6339302936339158","0.9104380373585327"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","RBF libSVM folded fingerprints regression","0.6269795611314886","0.9101657914525766"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Elastic Net on folded fingerprints regression","0.6352336327896249","0.9075314025107281"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Tanimoto Smile SVM regression","0.6583033668882773","0.9004161801233461"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","RBF Smile SVM descriptors regression","0.6867100816556578","0.8914696240321721"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Weka RF folded fingerprints regression","0.6886231137558061","0.8913994541716319"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Weka RF descriptors regression","0.7118846657824017","0.8833504414597176"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Weka RF descriptors regression","0.8411810182557296","0.1690944399989639"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Tanimoto Smile SVM regression","0.8693022459983557","0.15895100318900252"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Elastic Net on folded fingerprints regression","0.8387514612711574","0.14670143142387398"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Weka RF folded fingerprints regression","0.8422371508178672","0.12852919133572555"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Poly Smile SVM fingerprints regression","0.9153558320195108","0.1282211260222914"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","RBF libSVM folded fingerprints regression","0.8784710857581292","0.10928781742371041"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","RBF Smile SVM descriptors regression","0.9362929062137857","0.10455979021159134"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Tanimoto Smile SVM regression","0.4944859705636058","0.18469001699049428"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Weka RF descriptors regression","0.4831034478550642","0.1818030315213142"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Poly Smile SVM fingerprints regression","0.5012652018594468","0.16753115283352588"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Weka RF folded fingerprints regression","0.48180128089758756","0.16210516188498011"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Elastic Net on folded fingerprints regression","0.4819611213742905","0.14513205057009998"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","RBF libSVM folded fingerprints regression","0.5132324895161059","0.12771924047454758"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","RBF Smile SVM descriptors regression","0.5173934311974472","0.11665923452773537"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","RBF libSVM folded fingerprints regression","0.8200033017682024","0.7637892317893212"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Weka RF folded fingerprints regression","0.8326842171346036","0.7578786734217507"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Poly Smile SVM fingerprints regression","0.835629111783517","0.7536279399715451"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Tanimoto Smile SVM regression","0.8524796010232907","0.742494383244516"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","RBF Smile SVM descriptors regression","0.8979207646648129","0.7162080326712195"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Elastic Net on folded fingerprints regression","0.8952222563166595","0.7151149165580697"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Weka RF descriptors regression","0.9083201178643581","0.7043929454237805"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","RBF libSVM folded fingerprints regression","0.6976854640294513","0.862146448497976"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Weka RF folded fingerprints regression","0.7259696834136105","0.8502500933719579"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Poly Smile SVM fingerprints regression","0.7298130996501443","0.8482356250506554"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Tanimoto Smile SVM regression","0.7371276872109357","0.8462400074488043"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Elastic Net on folded fingerprints regression","0.7763144730558968","0.8271406875187223"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","RBF Smile SVM descriptors regression","0.8400815424506278","0.7974490309667518"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Weka RF descriptors regression","0.8411068110299026","0.7930603893610476"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Tanimoto Smile SVM regression","0.6362302153730359","0.8432557687309821"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Weka RF folded fingerprints regression","0.6490422740165251","0.8422899347114823"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","RBF libSVM folded fingerprints regression","0.6378586221090911","0.8388780297917852"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Poly Smile SVM fingerprints regression","0.6512171279218555","0.831538323250181"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Elastic Net on folded fingerprints regression","0.6936117448915168","0.8071139255327453"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","RBF Smile SVM descriptors regression","0.6982884312768113","0.8049789061843752"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Weka RF descriptors regression","0.7683501795314933","0.7561897541269792"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Tanimoto Smile SVM regression","0.6333762289839964","0.8725873448475253"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Weka RF descriptors regression","0.6958019581318987","0.8512272499241142"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","RBF libSVM folded fingerprints regression","0.6884419084680463","0.8463607276706783"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","RBF Smile SVM descriptors regression","0.6928528172365233","0.8462383830449232"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Weka RF folded fingerprints regression","0.7213617473746102","0.8319598009095212"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Poly Smile SVM fingerprints regression","0.7227650559892718","0.8286191612795992"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Elastic Net on folded fingerprints regression","0.8207896591907748","0.7801357002917256"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Tanimoto Smile SVM regression","0.6051933131641206","0.8456311586108596"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","RBF libSVM folded fingerprints regression","0.6234866251407507","0.8366703802185973"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Elastic Net on folded fingerprints regression","0.6742544331423116","0.8229681560211325"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Poly Smile SVM fingerprints regression","0.6625458563437482","0.8157342754771845"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Weka RF folded fingerprints regression","0.6743560849870448","0.8153722865370335"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","RBF Smile SVM descriptors regression","0.6916357161250447","0.793902577040392"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Weka RF descriptors regression","0.6965579303079863","0.7915545054705684"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Poly Smile SVM fingerprints regression","0.39120071614534707","0.48156803389431374"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","RBF libSVM folded fingerprints regression","0.40533574991382987","0.4532618613515662"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Weka RF folded fingerprints regression","0.3970062397556823","0.4492612570131765"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Tanimoto Smile SVM regression","0.4057856170087551","0.44427144204127933"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Elastic Net on folded fingerprints regression","0.4164530486774069","0.4074666173007697"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","RBF Smile SVM descriptors regression","0.4347910451444222","0.39500678186478877"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Weka RF descriptors regression","0.4249719765281738","0.312447396084448"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Weka RF folded fingerprints regression","0.8014320126268573","0.8065437295933994"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Poly Smile SVM fingerprints regression","0.820481724477942","0.7931068866340735"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","RBF libSVM folded fingerprints regression","0.8147206480091376","0.7924913789265279"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Elastic Net on folded fingerprints regression","0.8524378179487643","0.7702324217368398"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Tanimoto Smile SVM regression","0.8626761321662687","0.7636627890523983"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","RBF Smile SVM descriptors regression","0.9756968383131011","0.696958248899025"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Weka RF descriptors regression","0.9837985407235215","0.6832546220114997"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","RBF Smile SVM descriptors regression","0.5428187960708716","0.7791329612299149"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Tanimoto Smile SVM regression","0.5533513674053613","0.7640139489167174"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Weka RF descriptors regression","0.5626146287266122","0.7558715966765719"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Poly Smile SVM fingerprints regression","0.5607977542738419","0.753612672996478"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","RBF libSVM folded fingerprints regression","0.566145706056881","0.7484503817275681"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Weka RF folded fingerprints regression","0.5977717620732621","0.7335928879464029"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Elastic Net on folded fingerprints regression","0.6624313774081668","0.6374234122334177"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Poly Smile SVM fingerprints regression","0.9387830327310963","0.7267523441181288"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","RBF libSVM folded fingerprints regression","0.9338063783387481","0.7255319185723342"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","RBF Smile SVM descriptors regression","0.9732477715433375","0.6952566583690367"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Tanimoto Smile SVM regression","0.9790080039502078","0.6898655747917719"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Weka RF folded fingerprints regression","1.0116002388205836","0.6809259744149653"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Elastic Net on folded fingerprints regression","1.0345104625399502","0.6506156057942301"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Weka RF descriptors regression","1.0609767823841056","0.6263175041045146"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","RBF libSVM folded fingerprints regression","0.7478003576844866","0.8811288856841634"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Tanimoto Smile SVM regression","0.7545775509002359","0.8800608555100259"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Weka RF folded fingerprints regression","0.7745216099822784","0.8755440587505077"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Poly Smile SVM fingerprints regression","0.7879950690197444","0.8685302372391255"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","RBF Smile SVM descriptors regression","0.7944983178488922","0.8643513154276002"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Elastic Net on folded fingerprints regression","0.8057697447746427","0.8613988311993046"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Weka RF descriptors regression","0.8567691738432333","0.8456340618252296"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","RBF libSVM folded fingerprints regression","0.6700796700548647","0.792262101573726"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Poly Smile SVM fingerprints regression","0.6995125874624241","0.7719644791603575"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Weka RF folded fingerprints regression","0.7029801625662747","0.7655624617370849"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Tanimoto Smile SVM regression","0.7320938785284092","0.7472401366391515"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Elastic Net on folded fingerprints regression","0.7603898219819881","0.723888620029607"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Weka RF descriptors regression","0.8425087024658061","0.6446441530184277"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","RBF Smile SVM descriptors regression","0.9091676139981869","0.611593071752567"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","RBF libSVM folded fingerprints regression","0.6589289137802571","0.8584159609792384"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Poly Smile SVM fingerprints regression","0.6631586277022453","0.8566971761282589"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Tanimoto Smile SVM regression","0.6788022960414555","0.8506320575804304"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Weka RF folded fingerprints regression","0.7248399107463761","0.8350126285832967"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","RBF Smile SVM descriptors regression","0.7266418619529125","0.8250357557995661"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Elastic Net on folded fingerprints regression","0.7314590457495058","0.8248842046245091"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Weka RF descriptors regression","0.8044328456473112","0.7849147690459356"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Dose response cell-based high-throughput screening assay to measure PERK inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Weka RF folded fingerprints regression","0.03513829046537404","-0.025043177198419652"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Dose response cell-based high-throughput screening assay to measure PERK inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Weka RF descriptors regression","0.03808581683082537","-0.033424877160585134"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Dose response cell-based high-throughput screening assay to measure PERK inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","RBF Smile SVM descriptors regression","0.07453393226665452","-0.11879690920606545"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Dose response cell-based high-throughput screening assay to measure PERK inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Tanimoto Smile SVM regression","0.0810191876920248","-0.12538829833501575"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Dose response cell-based high-throughput screening assay to measure PERK inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","RBF libSVM folded fingerprints regression","0.08925461498032802","-0.13104796150785186"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Dose response cell-based high-throughput screening assay to measure PERK inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Poly Smile SVM fingerprints regression","0.09018879535548059","-0.1314594008734006"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Dose response cell-based high-throughput screening assay to measure PERK inhibition. (Class of assay: confirmatory) [Related pubchem assays: 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Elastic Net on folded fingerprints regression","0.03510883199415153","-0.1315774312366697"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Counterscreen assay for PERK inhibitors: Dose response cell-based high throughput screening assay to measure inhibition of PERK at 6 hours. (Class of assay: confirmatory) [Related pubchem assays: 1522 , 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Tanimoto Smile SVM regression","0.0","NaN"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Counterscreen assay for PERK inhibitors: Dose response cell-based high throughput screening assay to measure inhibition of PERK at 6 hours. (Class of assay: confirmatory) [Related pubchem assays: 1522 , 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Weka RF descriptors regression","8.881784197001252E-16","NaN"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Counterscreen assay for PERK inhibitors: Dose response cell-based high throughput screening assay to measure inhibition of PERK at 6 hours. (Class of assay: confirmatory) [Related pubchem assays: 1522 , 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","RBF Smile SVM descriptors regression","0.0","NaN"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Counterscreen assay for PERK inhibitors: Dose response cell-based high throughput screening assay to measure inhibition of PERK at 6 hours. (Class of assay: confirmatory) [Related pubchem assays: 1522 , 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","RBF libSVM folded fingerprints regression","0.0","NaN"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Counterscreen assay for PERK inhibitors: Dose response cell-based high throughput screening assay to measure inhibition of PERK at 6 hours. (Class of assay: confirmatory) [Related pubchem assays: 1522 , 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Poly Smile SVM fingerprints regression","0.0","NaN"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Counterscreen assay for PERK inhibitors: Dose response cell-based high throughput screening assay to measure inhibition of PERK at 6 hours. (Class of assay: confirmatory) [Related pubchem assays: 1522 , 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Elastic Net on folded fingerprints regression","7.105427357601002E-15","NaN"
"PEK","Activity Value","Assay Description:PubChem BioAssay. Counterscreen assay for PERK inhibitors: Dose response cell-based high throughput screening assay to measure inhibition of PERK at 6 hours. (Class of assay: confirmatory) [Related pubchem assays: 1522 , 1416 ]|Activity Type:EC50|Target Accession Numbers:NP_004827, SK281, Q9NZJ5, Q68DI6|Standard Unit:nM","118","Weka RF folded fingerprints regression","5.329070518200751E-15","NaN"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Tanimoto Smile SVM regression","0.5050657374154988","0.7090761881978787"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","RBF libSVM folded fingerprints regression","0.5080256070465796","0.7058711340201065"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Elastic Net on folded fingerprints regression","0.5123683377562083","0.6963709012428569"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Poly Smile SVM fingerprints regression","0.5167937461519425","0.6923696737442604"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Weka RF folded fingerprints regression","0.5310813678918703","0.692217397476874"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","RBF Smile SVM descriptors regression","0.6266651047202151","0.5138262101133623"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Weka RF descriptors regression","0.6367204809589717","0.45209590514411563"
